Medical Properties Trust, Inc. (NYSE:MPT) filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting net income of $202.1 million for the third quarter and $232.9 million for the nine months ended September 30, 2026.
Key Highlights
- Q3 2026 net income: $202.1 million, compared to a net loss of $77.5 million in Q3 2025, according to the filing.
- Nine-month net income: $232.9 million for the nine months ended September 30, 2026, versus a net loss of $293.5 million for the same period in 2025.
- Q3 earnings per share: $0.34 basic and diluted, attributable to MPT common stockholders, compared to a loss of $0.13 per share in Q3 2025.
- Total revenues: $250.1 million for Q3 2026, up from $237.5 million in Q3 2025; $761.5 million for the nine months, up from $701.7 million in the prior-year period.
- Gain on sale of real estate: $157.8 million recognized in Q3 2026, compared to a loss of $9.1 million in Q3 2025.
- Total assets: $14.39 billion as of September 30, 2026, down from $15.00 billion as of December 31, 2025.
- Dividends declared: $0.09 per common share for Q3 2026, bringing the nine-month total to $0.27 per share.
Medical Properties Trust Reports Q3 2026 Financial Results
According to the filing, Medical Properties Trust reported total revenues of $250.1 million for the three months ended September 30, 2026, compared to $237.5 million in the same quarter of 2025. Revenue components included rent billed of $195.3 million, straight-line rent of $35.7 million, income from financing leases of $10.1 million, and interest and other income of $9.0 million. Total expenses for Q3 2026 were $263.9 million, with interest expense of $153.1 million representing the largest component, followed by real estate depreciation and amortization of $70.3 million and general and administrative costs of $29.0 million.
The company disclosed total other income of $225.8 million for Q3 2026, driven primarily by a gain on sale of real estate of $157.8 million and a debt refinancing and unutilized financing benefit of $69.5 million. Real estate and other impairment charges, net, were $(23.9) million for the quarter. For the nine months ended September 30, 2026, impairment charges totaled $(59.7) million, compared to $(159.3) million in the prior-year nine-month period. Earnings from equity interests were $7.0 million in Q3 2026, compared to $34.4 million in Q3 2025.
The condensed consolidated balance sheet as of September 30, 2026 showed net investment in real estate assets of $10.67 billion and total debt, net of $9.26 billion, down from $9.70 billion at December 31, 2025. Total stockholders' equity attributable to Medical Properties Trust, Inc. was $4.62 billion. As of November 4, 2026, the company reported 588.9 million shares of common stock outstanding. Weighted average shares outstanding for Q3 2026 were 597,157 thousand (basic) and 597,162 thousand (diluted).
What Was Disclosed
Medical Properties Trust filed its quarterly report covering the three and nine months ended September 30, 2026, disclosing net income, revenue, expense, balance sheet, and per-share figures for both periods, along with the share count as of November 4, 2026.



Please wait processing your request...